Public statement: Risk of peripheral neuropathy with Sebivo (telbivudine)

View source ↗

Summary

EMA public statement warning about risk of peripheral neuropathy associated with Sebivo (telbivudine).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Viral Hepatitis

Drugs mentioned

• Sebivo (telbivudine)